跳至主要内容
临床试验/NL-OMON51250
NL-OMON51250招募中不适用

Pharmacokinetics and pharmacodynamics of corticosteroids in paediatric patients with autoimmune and autoinflammatory diseases - CARPE DIEM-study

niversitair Medisch Centrum Utrecht0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 17(—)

入选标准

  • 1. Patients treated by the WKZ with an autoimmune disease or autoinflammatory
  • disease including IBD;
  • 2. Patients both newly diagnosed and with refractory or relapsed disease with
  • an indication for systemic prednisolon;
  • 3. Planned to receive systemic prednisolone until at least one scheduled
  • follow-up visit between the 2nd and 6th week;
  • 4. Informed consent form (ICF) signed prior to participation in the study.

排除标准

  • None in advance. However, according to expert opninion of the principal
  • investigator, any disease/circumstance that may influence the participation of
  • the potential subject in a negative way, will be excluded from participation in
  • this study.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验